SECOND SIGHT MED PRODS INC - COM NEW (EYES)

CUSIP: 81362J209

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM NEW
Total 13F shares
683,815
Share change
+305,964
Total reported value
$1,277,000
Price per share
$1.86
Number of holders
15
Value change
+$696,711
Number of buys
12
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 81362J209?
CUSIP 81362J209 identifies EYES - SECOND SIGHT MED PRODS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM NEW (EYES) as of Q4 2020

As of 31 Dec 2020, SECOND SIGHT MED PRODS INC - COM NEW (EYES) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 683,815 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, JANE STREET GROUP, LLC, NORTHERN TRUST CORP, Squarepoint Ops LLC, Creative Planning, and WealthTrust Axiom LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.